Intravitreal bevacizumab for neovascular glaucoma

被引:9
作者
Jonas, Jost B. [1 ]
Golubkina, Lidia [1 ]
Libondi, Teodosio [1 ,2 ]
Rensch, Florian [1 ]
机构
[1] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, D-6900 Heidelberg, Germany
[2] Univ Naples 2, Dept Ophthalmol, Naples, Italy
关键词
PANRETINAL PHOTOCOAGULATION; INTRACAMERAL BEVACIZUMAB; IRIS NEOVASCULARIZATION; INJECTION; AVASTIN; RETINOPATHY;
D O I
10.1111/j.1755-3768.2008.01453.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:e22 / e23
页数:2
相关论文
共 20 条
[1]   A prospective study on intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration of different durations [J].
Algvere, Peep V. ;
Steen, Bjoern ;
Seregard, Stefan ;
Kvanta, Anders .
ACTA OPHTHALMOLOGICA, 2008, 86 (05) :482-489
[2]   Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy [J].
Arevalo, J. F. ;
Maia, M. ;
Flynn, H. W., Jr. ;
Saravia, M. ;
Avery, R. L. ;
Wu, L. ;
Farah, M. Eid ;
Pieramici, D. J. ;
Berrocal, M. H. ;
Sanchez, J. G. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (02) :213-216
[3]   Intravitreal bevacizumab (Avastin®) for radiation retinopathy neovascularization [J].
Arriola-Vilialobos, Pedro ;
Donate-Lopez, Juan ;
Calvo-Gonzalez, Cristina ;
Reche-Frutos, Juan ;
Alejandre-Alba, Nicolas ;
Diaz-Valle, David .
ACTA OPHTHALMOLOGICA, 2008, 86 (01) :115-116
[4]   Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma [J].
Chalam, K. V. ;
Gupta, S. K. ;
Grover, S. ;
Brar, V. S. ;
Agarwal, S. .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2008, 18 (02) :255-262
[5]   Bevacizumab (Avastin) for the treatment of neovascular glaucoma [J].
Chilov, Michael N. ;
Grigg, John R. ;
Playfair, T. Justin .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 35 (05) :494-496
[6]   Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity [J].
dell'Omo, Roberto ;
Kulkarni, Avinash ;
Franks, Wendy A. .
ACTA OPHTHALMOLOGICA, 2008, 86 (06) :698-700
[7]   Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma [J].
Ehlers, Justis P. ;
Spirn, Marc J. ;
Lam, Andrew ;
Sivalingam, Arunan ;
Samuel, Michael A. ;
Tasman, William .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (05) :696-702
[8]   Role of intravitreal bevacizumab in neovascular glaucoma [J].
Gheith, Moataz E. ;
Siam, Ghada A. ;
De Barros, Daniela S. Monteiro ;
Garg, Sunir J. ;
Moster, Marlene R. .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2007, 23 (05) :487-491
[9]   Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma [J].
Grover, S. ;
Gupta, S. ;
Sharma, R. ;
Brar, V. S. ;
Chalam, K. V. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (02) :273-274
[10]   Intravitreal bevacizumab (Avastin®) in the treatment of neovascular glaucoma [J].
Iliev, Milko E. ;
Domig, Diego ;
Wolf-Schnurrbursch, Ute ;
Wolf, Sebastian ;
Sarra, Gian-Marco .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (06) :1054-1056